MedPath

Clinical Study Comparing Dental Plaque and Gingivitis Reduction After Using One of Three Oral Hygiene Multi-component Regimens (Using of a Manual Toothbrush, a Toothpaste and a Mouthwash)

Phase 4
Completed
Conditions
Dental Plaque
Gingivitis
Interventions
Drug: Triclosan/fluoride toothpaste
Drug: stannous fluoride toothpaste
Drug: fluoride only toothpaste
Drug: Fluoride only mouthwash
Registration Number
NCT02366689
Lead Sponsor
Colgate Palmolive
Brief Summary

The objective of this clinical research study is to assess the efficacy of a commercially available triclosan/copolymer toothpaste compared to a commercially available oral hygiene multi-component regimen encompassing the use of a manual toothbrush, a toothpaste containing stannous fluoride / sodium hexametaphosphate and a mouthwash containing cetylpyridinium chloride relative to a negative control regimen in reducing established dental plaque and gingivitis over three and six months of assigned product use.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
179
Inclusion Criteria
  1. Male and female subjects, ages 18-70, inclusive.
  2. Availability for the six-month duration of the study.
  3. Good general health.
  4. Minimum of 20 uncrowned permanent natural teeth (excluding third molars).
  5. Initial gingivitis index of at least 1.0 as determined by the use of the Loe and Silness Gingival Index.
  6. Initial plaque index of at least 1.5 as determined by the use of the Quigley and Hein Plaque Index (Turesky Modification).
  7. Signed Informed Consent Form.
Exclusion Criteria
  1. Presence of orthodontic bands.
  2. Presence of partial removable dentures.
  3. Tumor(s) of the soft or hard tissues of the oral cavity.
  4. Advanced periodontal disease (purulent exudate, tooth mobility, and/or extensive loss of periodontal attachment or alveolar bone).
  5. Five or more carious lesions requiring immediate restorative treatment.
  6. Use of antibiotics any time during the one month prior to entry into the study.
  7. Participation in any other clinical study or test panel within the one month prior to entry into the study.
  8. Pregnant women or women who are breast feeding.
  9. Dental prophylaxis received in the past two weeks prior to baseline examinations.
  10. History of allergies to oral care/personal care consumer products or their ingredients.
  11. On any prescription medicines that might interfere with the study outcome.
  12. An existing medical condition which prohibits eating or drinking for periods up to 4 hours.
  13. History of alcohol or drug abuse

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ToothpasteTriclosan/fluoride toothpasteTriclosan/fluoride toothpaste
Toothpaste + mouthwashstannous fluoride toothpastestannous fluoride toothpaste + cetylpyridinium chloride Mouthwash
Toothpaste + mouthwashCetylpyridinium chloride mouthwashstannous fluoride toothpaste + cetylpyridinium chloride Mouthwash
Fluoride only Toothpaste + mouthwashfluoride only toothpasteFluoride only toothpaste + Fluoride only Mouthwash
Fluoride only Toothpaste + mouthwashFluoride only mouthwashFluoride only toothpaste + Fluoride only Mouthwash
Primary Outcome Measures
NameTimeMethod
Gingivitis Scores6 months

Gingivitis scale (Loe \& Silness Gingival Index) Units on a scale 0 to 3 (0 = no inflammation, 1 = Mild inflammation-slight change in color and little change in texture 2 = Moderate inflammation-moderate glazing, redness, edema and hypertrophy. Tendency to bleed upon probing. 3 = Severe inflammation-marked redness and hypertrophy. Tendency to spontaneous bleeding)

Dental Plaque Scores6 months

Dental Plaque (Quigley-Hein, Turesky Modification Index) Units on a scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque, 3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Concordia Clinical Research

🇺🇸

Cedar Knolls, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath